Concepedia
Statistics
Publications
32
Citations
2.4K
H-Index
23
Active since
1996
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
University of Glasgow
Institut Gustave Roussy
AstraZeneca (Singapore)
Claire Rooney is an author at AstraZeneca (United Kingdom) specializing in oncology, medicine, and molecular oncology.
Publications per year
1996–2025
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine, Lorraine Mooney, Elaine Kilgour et al. · Cancer Research · 2012 · 499 citations
Medicine, Oncology, Pharmacology +16
High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 276 citations · Full text
Medicine, Cancer Biology, Oncology +17
Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS
Sarah J. Ross, Alexey S. Revenko, Lyndsey Hanson et al. · Science Translational Medicine · 2017 · 182 citations
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Paul K. Paik, Ronglai Shen, Michael F. Berger et al. · Clinical Cancer Research · 2017 · 147 citations · Full text
Medicine, Oncology, Pharmacology +11
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade
Lynda Vuong, Eleni Kouverianou, Claire Rooney et al. · Cancer Research · 2019 · 141 citations · Full text
Medicine, Immunology, Oncology +16
1–5 of 32